Cargando…
Cardiovascular diseases risk evaluation in newly diagnosed type-2 diabetics: An association of novel biomarkers apo proteins and C-peptide
Autor principal: | Purohit, Purvi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510950/ https://www.ncbi.nlm.nih.gov/pubmed/23226676 http://dx.doi.org/10.4103/2230-8210.103052 |
Ejemplares similares
-
Raised liver enzymes in newly diagnosed type 2 diabetes
por: Joob, Beuy, et al.
Publicado: (2013) -
Newly diagnosed diabetes in COVID-19 patients
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021) -
Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
In response to: “Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic”
por: Cimbek, Emine Ayça, et al.
Publicado: (2022) -
Proposal of a Novel Risk Score for Determination of Coronary Artery Disease Risk in Newly Diagnosed Diabetes Patients
por: VESA, Cosmin Mihai, et al.
Publicado: (2020)